Skip to main content

The Many Roles of Malaria in the Etiology of Endemic Burkitt Lymphoma

  • Chapter
  • First Online:
  • 970 Accesses

Part of the book series: Current Cancer Research ((CUCR))

Abstract

The weight of both epidemiologic and molecular studies confirms that malaria is an etiologic cofactor in endemic Burkitt’s lymphoma (eBL). This chapter will review the literature on the epidemiologic association of eBL with areas of Africa and Papua New Guinea where malaria transmission is holoendemic as well as studies revealing potential mechanisms by which malaria could contribute to the increased incidence of eBL.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Burkitt D (1958) A sarcoma involving the jaws in African children. Br J Surg 46:218–223

    Article  PubMed  CAS  Google Scholar 

  2. Burkitt D (1962) A “tumour safari” in East and Central Africa. Br J Cancer 16:379–386

    Article  PubMed  CAS  Google Scholar 

  3. Haddow AJ (1963) An improved map for the study of Burkitt’s lymphoma syndrome in Africa. East Afr Med J 40:429–432

    PubMed  CAS  Google Scholar 

  4. Booth K, Burkitt DP, Bassett DJ, Cooke RA, Biddulph J (1967) Burkitt lymphoma in Papua, New Guinea. Br J Cancer 21:657–664

    Article  PubMed  CAS  Google Scholar 

  5. Burkitt D (1962) Determining the climatic limitations of a children’s cancer common in Africa. Br Med J 5311:1019–1023

    Article  Google Scholar 

  6. Wright DH (1967) The epidemiology of Burkitt’s tumor. Cancer Res 27:2424–2438

    PubMed  CAS  Google Scholar 

  7. Dalldorf G (1962) Lymphomas of African children. JAMA 181:1026–1028

    Article  PubMed  CAS  Google Scholar 

  8. Morrow RH (1985) Epidemiological evidence for the role of faciparum malaria in the pathogenesis of Burkitt’s lymphoma. In: Lenoir G, O’Connor G, Olweny C (eds) Burkitt’s lymphoma: a human cancer model, vol 60. IARC Press, Lyons, pp 177–185

    Google Scholar 

  9. Rainey JJ, Mwanda WO, Wairiumu P, Moormann AM, Wilson ML, Rochford R (2007) Spatial distribution of Burkitt’s lymphoma in Kenya and association with malaria risk. Trop Med Int Health 12:936–943

    Article  PubMed  Google Scholar 

  10. Morrow RH, Kisuule A, Pike MC, Smith PG (1976) Burkitt’s lymphoma in the Mengo Districts of Uganda: epidemiologic features and their relationship to malaria. J Natl Cancer Inst 56:479–483

    PubMed  CAS  Google Scholar 

  11. Burkitt D, Wright D (1966) Geographical and tribal distribution of the African lymphoma in Uganda. Br Med J 5487:569–573

    Article  Google Scholar 

  12. Mutalima N, Molyneux E, Jaffe H et al (2008) Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case–control study. PLoS One 3:e2505

    Article  PubMed  Google Scholar 

  13. Carpenter LM, Newton R, Casabonne D et al (2008) Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case–control study in Uganda. Int J Cancer 122:1319–1323

    Article  PubMed  CAS  Google Scholar 

  14. Emmanuel B, Kawira E, Ogwang MD et al (2011) African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg 84:397–401

    Article  PubMed  Google Scholar 

  15. Marsh K, Otoo L, Hayes RJ, Carson DC, Greenwood BM (1989) Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg 83:293–303

    Article  PubMed  CAS  Google Scholar 

  16. Snow RW, Omumbo JA, Lowe B et al (1997) Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 349:1650–1654

    Article  PubMed  CAS  Google Scholar 

  17. Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E (2007) Burkitt’s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci 7:166–175

    PubMed  Google Scholar 

  18. Ho M, Webster HK, Looareesuwan S et al (1986) Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis 153:763–771

    Article  PubMed  CAS  Google Scholar 

  19. Ho M, Webster HK, Green B, Looareesuwan S, Kongchareon S, White NJ (1988) Defective production of and response to IL-2 in acute human falciparum malaria. J Immunol 141:2755–2759

    PubMed  CAS  Google Scholar 

  20. Hviid L, Jakobsen PH, Abu-Zeid YA, Theander TG (1992) T-cell responses in malaria. APMIS 100:95–106

    Article  PubMed  CAS  Google Scholar 

  21. Mabey DC, Brown A, Greenwood BM (1987) Plasmodium falciparum malaria and Salmonella infections in Gambian children. J Infect Dis 155:1319–1321

    Article  PubMed  CAS  Google Scholar 

  22. Cook IF (1985) Herpes zoster in children following malaria. J Trop Med Hyg 88:261–264

    PubMed  CAS  Google Scholar 

  23. Thursz MR, Kwiatkowski D, Torok ME et al (1995) Association of hepatitis B surface antigen carriage with severe malaria in Gambian children. Nat Med 1:374–375

    Article  PubMed  CAS  Google Scholar 

  24. Whittle HC, Brown J, Marsh K et al (1984) T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature 312:449–450

    Article  PubMed  CAS  Google Scholar 

  25. Gunapala DE, Facer CA, Davidson R, Weir WR (1990) In vitro analysis of Epstein-Barr virus: host balance in patients with acute Plasmodium falciparum malaria. I. Defective T-cell control. Parasitol Res 76:531–535

    Article  PubMed  CAS  Google Scholar 

  26. Williamson WA, Greenwood BM (1978) Impairment of the immune response to vaccination after acute malaria. Lancet 1:1328–1329

    Article  PubMed  CAS  Google Scholar 

  27. Moormann AM, Chelimo K, Sumba OP et al (2005) Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 191:1233–1238

    Article  PubMed  Google Scholar 

  28. Hogh B (1996) Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children. Scand J Infect Dis Suppl 102:1–53

    PubMed  CAS  Google Scholar 

  29. O’Conor GT (1970) Persistent immunologic stimulation as a factor in oncogenesis with special reference to Burkitt’s tumor. Am J Med 48:279–285

    Article  Google Scholar 

  30. Nagaoka H, Gonzalez-Aseguinolaza G, Tsuji M, Nussenzweig MC (2000) Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production. J Exp Med 191:2113–2120

    Article  PubMed  CAS  Google Scholar 

  31. Weiss GE, Crompton PD, Li S et al (2009) Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol 183:2176–2182

    Article  PubMed  CAS  Google Scholar 

  32. Donati D, Zhang LP, Chen Q et al (2004) Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun 72:5412–5418

    Article  PubMed  CAS  Google Scholar 

  33. Greenwood BM, Oduloju AJ, Platts-Mills TA (1979) Partial characterization of a malaria mitogen. Trans R Soc Trop Med Hyg 73:178–182

    Article  PubMed  CAS  Google Scholar 

  34. Greenwood BM (1974) Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet 1:435–436

    Article  PubMed  CAS  Google Scholar 

  35. Njie R, Bell AI, Jia H et al (2009) The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children. J Infect Dis 199:31–38

    Article  PubMed  Google Scholar 

  36. Donati D, Espmark E, Kironde F et al (2006) Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment. J Infect Dis 193:971–977

    Article  PubMed  CAS  Google Scholar 

  37. Rasti N, Falk KI, Donati D et al (2005) Circulating Epstein-Barr virus in children living in malaria-endemic areas. Scand J Immunol 61:461–465

    Article  PubMed  CAS  Google Scholar 

  38. Yone CL, Kube D, Kremsner PG, Luty AJ (2006) Persistent Epstein-Barr viral reactivation in young African children with a history of severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 100:669–676

    Article  PubMed  CAS  Google Scholar 

  39. Lam KM, Syed N, Whittle H, Crawford DH (1991) Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet 337:876–878

    Article  PubMed  CAS  Google Scholar 

  40. Piriou E, Kimmel R, Chelimo K et al (2009) Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med Virol 81:1088–1093

    Article  PubMed  CAS  Google Scholar 

  41. Chene A, Donati D, Guerreiro-Cacais AO et al (2007) A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog 3:e80

    Article  PubMed  Google Scholar 

  42. Hoshino Y, Katano H, Zou P et al (2009) Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers. J Virol 83:11857–11861

    Article  PubMed  CAS  Google Scholar 

  43. Parroche P, Lauw FN, Goutagny N et al (2007) Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A 104:1919–1924

    Article  PubMed  CAS  Google Scholar 

  44. Peng SL (2005) Signaling in B cells via Toll-like receptors. Curr Opin Immunol 17:230–236

    Article  PubMed  CAS  Google Scholar 

  45. Piriou E, Asito AS, Sumba OP et al (2012) Early age of primary EBV infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis 205(6):906–913

    Article  PubMed  Google Scholar 

  46. de-The G (1977) Is Burkitt’s lymphoma related to perinatal infection by Epstein-Barr virus? Lancet 1:335–338

    Article  PubMed  CAS  Google Scholar 

  47. Paschos K, Smith P, Anderton E, Middeldorp JM, White RE, Allday MJ (2009) Epstein-Barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog 5:e1000492

    Article  PubMed  Google Scholar 

  48. Babcock GJ, Thorley-Lawson DA (2000) Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc Natl Acad Sci U S A 97:12250–12255

    Article  PubMed  CAS  Google Scholar 

  49. Capolunghi F, Cascioli S, Giorda E et al (2008) CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 180:800–808

    PubMed  CAS  Google Scholar 

  50. Potup P, Kumsiri R, Kano S et al (2009) Blood stage Plasmodium falciparum antigens induce immunoglobulin class switching in human enriched B cell culture. Southeast Asian J Trop Med Public Health 40:651–664

    PubMed  CAS  Google Scholar 

  51. Ramiro AR, Jankovic M, Callen E et al (2006) Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440:105–109

    Article  PubMed  CAS  Google Scholar 

  52. Brady G, MacArthur GJ, Farrell PJ (2007) Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol 60:1397–1402

    PubMed  CAS  Google Scholar 

  53. Moss DJ, Burrows SR, Castelino DJ et al (1983) A comparison of Epstein-Barr virus-specific T-cell immunity in malaria- endemic and -nonendemic regions of Papua New Guinea. Int J Cancer 31:727–732

    Article  PubMed  CAS  Google Scholar 

  54. Whittle HC, Brown J, Marsh K, Blackman M, Jobe O, Shenton F (1990) The effects of Plasmodium falciparum malaria on immune control of B lymphocytes in Gambian children. Clin Exp Immunol 80:213–218

    Article  PubMed  CAS  Google Scholar 

  55. Moormann AM, Chelimo K, Sumba PO, Tisch DJ, Rochford R, Kazura JW (2007) Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis 195:799–808

    Article  PubMed  CAS  Google Scholar 

  56. Hviid L, Kurtzhals JA, Adabayeri V et al (2001) Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria. Infect Immun 69:3190–3196

    Article  PubMed  CAS  Google Scholar 

  57. Hviid L, Kurtzhals JA, Dodoo D et al (1996) The gamma/delta T-cell response to Plasmodium falciparum malaria in a population in which malaria is endemic. Infect Immun 64:4359–4362

    PubMed  CAS  Google Scholar 

  58. Futagbi G, Welbeck JE, Tetteh JK, Hviid L, Akanmori BD (2007) Selective activation of TCR-gammadelta+ cells in endemic Burkitt’s lymphoma. Malar J 6:69

    Article  PubMed  Google Scholar 

  59. Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF (2007) Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 27:334–348

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rosemary Rochford .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer New York

About this chapter

Cite this chapter

Rochford, R., Asito, A.S. (2013). The Many Roles of Malaria in the Etiology of Endemic Burkitt Lymphoma. In: Robertson, E. (eds) Burkitt’s Lymphoma. Current Cancer Research. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4313-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4313-1_13

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-4312-4

  • Online ISBN: 978-1-4614-4313-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics